A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants
Clinical trial NCT05668936 · TERMINATED
Trial details
- NCT number
- NCT05668936
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-03
- Primary completion
- 2023-03-10
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.